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Abstract: Dementia is defined as a severe form of cognitive impairment. Research concerning the
two-way relationship between depression and cognitive impairment has been conducted; however,
there has been little analysis of cognitive function following changes in depressive status. This study
describes the association between changes in depressive state and cognitive function in a Korean
geriatric population sample. Using the Korean Longitudinal Study of Aging (KLoSA) database,
Mini-Mental State Examination (MMSE) scores and Center for Epidemiologic Studies Depression
Scale (CESD-10) indexes were used for measuring cognitive function and depression, respectively.
The survey population was divided into four case categories by change in depressive status: normal to
normal (Group A), normal to depressive (Group B), depressive to normal (Group C), and depressive
to depressive (Group D). Analysis of variance, multiple regression analysis, and subgroup analysis
were used for statistical examination. In the multiple regression analysis between MMSE values
and depressive status change groups, with Group A as the reference, β in all other groups was
negative, and its absolute value was large in the order of D, B, and C in both men (B: −0.717, C:
−0.416, D: −1.539) and women (B: −0.629, C: −0.430, D: −1.143). There were also significant results
in the subgroup analysis in terms of age, working status, participation in social activities, regular
physical activities, and number of chronic medical conditions. In conclusion, both cases—those
suffering from depression and those having suffered from it before—experience cognitive impairment.
The degree of cognitive function being impaired is greater in the case of depression-onset than that of
depression-remission. Age, stimulating activities, and chronic conditions are also strongly relevant to
cognitive decline accompanied by changes in depressive state.
Keywords: depression change; cognitive function; cognitive impairment
1. Introduction
One of the many visible trends in an aging population is a decline in cognitive abilities. While such
symptoms may be expected as one ages, it may also point to the onset of geriatric neurodegenerative
diseases. In particular, dementia is a severe form of cognitive impairment. As one of the most common
diseases in the world, the number of patients is expected to increase from around 47 million globally in
2015 to 66 million by 2030 and 115 million by 2050 [1]. Because dementia is accompanied by serious
cognitive impairment, affecting one’s everyday life, it is a heavy burden for those with the disease,
their families, and society [2].
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Among many neuropsychiatric symptoms, depression is reported to be correlated with both
cognitive impairment [3–5] and dementia [6,7]. In one umbrella review, late-life depression was
considered to be a convincing environmental risk factor for all types of dementia, and it is postulated
that “depression may be an early reaction to perceived cognitive decline” [8]. In the DSM-5 (Diagnostic
and Statistical Manual of Mental Disorders, Fifth Edition), one of the diagnosis criteria for major
depressive disorder—“diminished ability to think or concentrate, or indecisiveness, nearly every
day”—seems to infer the association between a depressive state and cognitive decline as well [9].
With growing evidence suggesting the possible linkage between depressive symptoms and
cognitive decline, numerous researches have been conducted to gain advanced understanding of
the association. This research has suggested the negative impact of both depression-onset and
depression-remission on cognitive function [4,5,10], which is supported by some studies suggesting
that cognitive deficits are at least a persistent feature, if not a core symptom, of depression [4,11–13].
However, as these studies only account for cognitive abilities corresponding to a one-sided change in
depressive state—‘good to bad’ or ‘bad to good’—direct comparison between changes in cognitive
function corresponding to the two opposite depression change directions seems to be inappropriate due
to differences in the data employed or variations in the study design. Accordingly, we multi-directionally
investigated the association between the change in depressive state and cognitive function, measured
by the Center for Epidemiologic Studies Depression Scale (CESD-10) index and Mini-Mental State
Examination (MMSE), respectively, using the Korean Longitudinal Study of Aging (KLoSA) database.
2. Method
2.1. Study Population
The Korean Longitudinal Study of Aging database compiles data from the Korean population
aged above 45 years (with the exception of those inhabiting Jeju Island). Every two years, beginning in
2006, a self-reported baseline survey has been conducted of the study population. Every two years
since 2007, a self-reported in-depth survey of the study population on topics not examined in the
baseline survey has been conducted. Baseline data are categorized into eight groups: population,
family (children and grandchildren), family (parents and siblings), health status, employment, income,
assets, and subjective quality of life. In this study, however, the first baseline survey was excluded,
because CESD-10, one of our key variables, was not surveyed in 2006. Moreover, the most recent
survey, the seventh baseline survey, was conducted in 2018, but the data are not yet available for
general use. Therefore, in our study we employed baseline survey data from 2008 to 2016, resulting in
a total of five datasets.
Baseline characteristics were analyzed for the study population in 2008. Deletion of data with
missing values for the key variables as well as covariates resulted in a total of 3031 for the male
population and 3958 for the female population. For statistical analysis, each change in depression
status in the population from 2008 to 2016, rather than the population number itself, was treated as an
individual case.
2.2. Variables
For measurement of cognitive function, the Mini-Mental State Examination score was used [14,15].
This was categorized by the KLoSA database as follows: normal (24 or more), mild cognitive impairment
(18–23), and dementia (17 or less). We used the mean MMSE score, however, which means that the
MMSE score was employed as a raw index, because the MMSE alone is not appropriate for diagnostic
purpose [16,17] and we wanted to examine the results in detail.
For measurement of depressive state, the Center for Epidemiologic Studies Depression Scale score
was used [18,19]. While the KLoSA database provides the score as a raw index ranging from 0 to 10,
we categorized those who score 3 or less as normal and those who score 4 or more as depressive [19]
for the purpose of our study. The development of depression in individuals across each survey period,
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meaning changes in depressive status from the participant’s previous responses, was considered to
be a separate case. Thus, if a participant had n changes in depression state over the five waves of
the survey, he or she would account for n cases. Each case was then categorized in order to divide
the survey population into four case groups. For simplicity, each group (termed ‘depression change
groups’) was assigned a label:
• Group A, normal to normal (without depression for the past two years);
• Group B, normal to depressive (having developed depression in the past two years);
• Group C, depressive to normal (having been cured of depression in the past two years);
• Group D, depressive to depressive (having depression for the past two years).
This categorization allowed the comparison of MMSE scores between depression change groups.
2.3. Covariates
Demographic characteristics were included as covariates. The covariates are listed as follows:
age (categorical: 45–54, 55–64, 65–74, or 75 years and over), educational level (categorical: elementary
school or less, middle school, high school, or university or beyond), region (categorical: metropolitan
or rural), working status (categorical: working or non-working), household income (categorical: low,
mid-low, mid-high, or high), participation in social activities (categorical: no or yes), perceived health
status (categorical: healthy, average, or unhealthy), regular physical activities (categorical: yes or
no), smoking (categorical: current, former, or never), alcohol intake (categorical: yes or no), number
of chronic medical conditions (categorical: none, 1, or ≥2), weight change of ≥5 kg in the past year
(categorical: no change, increase, decrease, or fluctuations), and number of cohabiting generations
(categorical: couple, two generations, or over two generations). All multivariable models controlled
for all covariates unless stated otherwise.
2.4. Statistical Analysis
All analysis was carried out separately for men and women. Analysis of variance (ANOVA)
was carried out to obtain descriptive statistics. To confirm the patterns of difference among the
interesting variable groups (changes in depressive state), we performed post hoc analysis using the
Tukey method. A generalized estimating equation (GEE) model was employed for regression analysis
between MMSE scores and the dependent variables, including depression development. Regression
coefficients, indicated as β, and standard errors were thus acquired.
Subgroup analysis was performed for in-depth study into interactions between depression and
other variables with regards to MMSE scores. Other variables included working status, participation in
social activities, regular physical activities, number of chronic medical conditions, and weight change
of ≥5 kg in the past year.
All p-values were accepted as significant if lower than 0.05. A p-value lower than 0.001 was
considered to indicate a very high significance level. All analyses were performed using SAS software,
version 9.4 (SAS Institute, Cary, North Carolina, CA, USA).
3. Results
Baseline characteristics are displayed in Table 1. Effect size among three different models was
also examined (Table A1). It is also noted that the variance inflation value for the multicollinearity of
the covariates included in this study ranged from 1.03 to 2.03, which means that the variables were
independent. It is notable that the differences in the mean MMSE scores between depression change
groups are considered highly statistically significant (p< 0.0001). Post hoc analysis using the Tukey method
showed statistically significant differences between all groups (Tables A2 and A3). Other covariates such
as age, educational level, working status, participation in social activities, perceived health status, regular
physical activities, and weight change of ≥5kg in the past year were also highly significant for both men
and women (p < 0.0001). Household income was also significant for both sexes (p < 0.05).
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Table 1. Baseline characteristics of study population by MMSE (Mini-Mental State Examination).
Variables
Men Women
Subjects MMSE Subjects MMSE
n % Mean ± S.D p-Value n % Mean ± S.D p-Value
Changes in Depressive State <0.0001 <00.0001
Normal to Normal (Group A) 1386 45.7 25.947 2.662 1334 33.7 24.706 4.077
Normal to Depressive (Group B) 476 15.7 24.487 3.802 566 14.3 23.339 4.896
Depressive to Normal (Group C) 398 13.1 25.618 3.147 650 16.4 23.922 4.715
Depressive to Depressive (Group D) 771 25.4 22.551 5.673 1408 35.57 21.031 5.932
Age <0.0001 <0.0001
45–54 582 19.2 26.440 2.296 821 20.7 26.055 2.464
55–64 971 32.0 25.837 3.031 1159 29.3 25.144 3.180
65–74 938 31.0 24.239 4.432 1144 28.9 22.543 4.534
≥75 540 17.8 22.202 5.189 834 21.1 17.993 6.507
Education level <0.0001 <0.0001
Elementary school or less 950 31.3 22.878 5.160 2300 58.1 21.297 5.703
Middle school 536 17.7 25.095 3.617 658 16.6 25.044 3.488
High school 1046 34.5 25.815 2.904 833 21.1 25.772 3.117
University or beyond 499 16.5 26.078 3.144 167 4.2 26.341 2.524
Region 0.5899 0.0802
Metropolitan 1320 43.6 25.136 3.842 1767 44.6 23.508 5.055
Rural 1711 56.5 24.560 4.307 2191 55.4 22.724 5.400
Working Status <0.0001 <0.0001
Working 1806 59.6 25.841 2.780 1248 31.5 24.901 3.488
Non-working 1225 40.4 23.291 5.173 2710 68.5 22.233 5.710
Household income 0.0148 0.0178
Low 746 24.6 22.724 5.224 1274 32.2 20.983 5.653
Mid-low 762 25.1 24.790 3.720 932 23.6 23.523 4.685
Mid-high 818 27.0 25.540 3.343 933 23.6 24.046 4.987
High 705 23.3 26.194 3.022 819 20.7 24.711 4.484
Participation in social activities <.0001 <0.0001
No 680 22.4 22.500 5.852 1101 27.8 20.096 6.332
Yes 2351 77.6 25.479 3.163 2857 72.2 24.222 4.264
Perceived health status <0.0001 <0.0001
Healthy 1618 53.4 25.936 2.723 1561 39.4 25.020 3.708
Average 910 30.0 24.541 3.699 1363 34.4 23.045 4.907
Unhealthy 503 16.6 21.678 6.306 1034 26.1 20.176 6.279
Regular physical activities <0.0001 <0.0001
Yes 1156 38.1 25.612 2.975 1213 30.7 24.788 3.699
No 1875 61.9 24.317 4.622 2745 69.4 22.317 5.658
Smoking 0.0972 0.4543
Current 1119 36.9 25.188 3.631 119 3.0 21.378 5.678
Former 905 29.9 24.659 4.202 63 1.6 20.302 7.570
Never 1007 33.2 24.528 4.512 3776 95.4 23.174 5.181
Alcohol intake 0.1058 0.3768
Yes 1772 58.5 25.396 3.368 721 18.2 24.408 4.160
No 1259 41.5 23.986 4.875 3237 81.8 22.777 5.434
Number of chronic medical conditions 0.0366 0.1106
None 1345 44.4 25.687 3.122 1486 37.5 24.387 4.711
1 898 29.6 24.793 3.851 1280 32.3 23.116 5.064
≥2 788 26.0 23.335 5.322 1192 30.1 21.393 5.639
Weight change of ≥5kg in the past year <0.0001 <0.0001
No change 2282 75.3 25.309 3.491 2883 72.84 23.503 5.063
Increase 101 3.3 24.228 4.025 214 5.41 23.888 4.111
Decrease 369 12.2 22.751 5.803 454 11.47 21.211 5.749
Fluctuations 279 9.2 23.667 5.055 407 10.28 21.686 5.890
Number of cohabiting generations 0.2681 0.0028
Couple 1420 46.9 24.204 4.437 1896 47.9 22.760 4.998
Two generations 1288 42.5 25.544 3.460 1502 38.0 24.003 5.110
Over two generations 323 10.7 24.554 4.617 560 14.2 21.648 6.046
Total 3031 100 24.811 4.121 3958 100 23.074 5.262
Table 2 shows multiple regression analysis results between MMSE values and depression change
groups. Group A was set as the reference value. For men, the regression coefficient is shown to have a
decrease of 0.717 in Group B, a lesser decrease of 0.416 in Group C, and a greater decrease of 1.539 in
Group D. Similarly, women’s cases in Group B show a regression coefficient of −0.629, a value of −0.430
in Group C, and a more negative regression coefficient of −1.413 in Group D. This trend of the degree of
cognitive impairment being severe in the order of Group D, B, C, and A is also shown in Tables A4–A6,
which include parallel multiple regression analyses setting Group B–D as the reference, respectively.
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Table 2. Results of analyzing factors associated with MMSE (Mini-Mental State Examination).
Variables
Men Women
β S.E p-Value β S.E p-Value
Changes in Depressive State
Normal to Normal (Group A) Ref. Ref.
Normal to Depressive (Group B) −0.717 0.102 <0.0001 −0.629 0.097 <0.0001
Depressive to Normal (Group C) −0.416 0.094 <0.0001 −0.430 0.087 <0.0001
Depressive to Depressive (Group D) −1.539 0.108 <0.0001 −1.413 0.104 <0.0001
Age
45–54 Ref. Ref.
55–64 0.362 0.089 <0.0001 0.423 0.079 <0.0001
65–74 0.123 0.125 0.3240 −0.460 0.122 0.0002
≥75 −0.722 0.174 <0.0001 −2.836 0.167 <0.0001
Education level
Elementary school or less −2.423 0.169 <0.0001 −4.521 0.179 <0.0001
Middle school −0.602 0.160 0.0002 −1.243 0.175 <0.0001
High school −0.232 0.117 0.0464 −0.434 0.150 0.0039
University or beyond Ref. Ref.
Region
Metropolitan Ref. Ref.
Rural −0.065 0.102 0.5243 −0.332 0.106 0.0018
Working Status
Working Ref. Ref.
Non–working −0.698 0.091 <0.0001 −0.646 0.080 <0.0001
Household income
Low −1.150 0.145 <0.0001 −0.295 0.141 0.0363
Mid–low −0.145 0.094 0.0060 0.267 0.119 0.0251
Mid–high −0.145 0.094 0.1205 0.137 0.104 0.1889
High Ref. Ref.
Participation in social activities
No −1.734 0.127 <0.0001 −1.654 0.105 <0.0001
Yes Ref. Ref.
Perceived health status
Healthy Ref. Ref.
Average −0.343 0.068 <0.0001 −0.442 0.073 <0.0001
Unhealthy −2.281 0.145 <0.0001 −2.085 0.116 <0.0001
Regular physical activities
Yes 0.587 0.077 <0.0001 0.671 0.072 <0.0001
No Ref. Ref.
Smoking
Current 0.371 0.121 0.0022 0.109 0.333 0.7445
Former 0.187 0.126 0.1384 −0.649 0.399 0.1040
Never Ref. Ref.
Alcohol intake
Yes 0.357 0.093 0.0001 0.541 0.108 <0.0001
No Ref. Ref.
Number of chronic medical conditions
None Ref. Ref.
1 0.077 0.100 0.4414 0.261 0.115 0.0226
≥2 −0.148 0.126 0.2413 0.108 0.142 0.4461
Weight change of ≥5kg in the past year
No change Ref. Ref.
Increase −0.172 0.128 0.1785 0.086 0.105 0.4153
Decrease −0.677 0.123 <0.0001 −0.395 0.109 0.0003
Fluctuations –1.115 0.189 <0.0001 −1.395 0.175 <0.0001
Number of cohabiting generations
Couple 0.702 0.171 <0.0001 0.996 0.156 <0.0001
Two generations 0.308 0.166 0.0626 0.423 0.157 0.0070
Over two generations Ref. Ref.
It is notable that Group C shows the smallest decrease in the regression coefficient for both sexes;
Group D, on the other hand, shows the largest decrease in the coefficient for both genders. The results
of other covariates can also be observed: age groups for one show significant results. In particular,
while the regression coefficient can be observed to increase until the age of 64, a definite decrease in the
coefficient is seen in both men and women who are 75 years of age or older. Educational level is also
a highly significant variable, as a lower educational level tends to result in a diminished regression
coefficient in both sexes. Those with an educational level of elementary school or less, especially, show
a strong decrease in the regression coefficient when compared with the group of university education
Int. J. Environ. Res. Public Health 2019, 16, 4944 6 of 11
or beyond. It is also notable that the regression coefficient for women is about twice that of men in
each category, meaning a steeper difference trend from the reference value for women.
In terms of weight change, fluctuations and a decrease in weight were both seen to result in a decrease
in the regression coefficient compared with no change, with fluctuations being especially significant. It is
also noted that compared with those living with family over two generations, those living only with a
spouse had the greatest regression coefficient, followed by those living with two generations. Women in
rural areas show a lower regression coefficient, while region seems to have little significance in men. Low
and mid-low household income levels show decreased regression coefficients in men, compared with the
high household income level. In women, the mid-low household income group shows a greater regression
coefficient compared with the high household income group, whereas the low household income group
has a lesser one. Working status, participation in social activities, physical activities, alcohol intake, and
perceived health status were revealed to be important factors, with those working, participating in social
activities, doing regular physical activities, drinking, and with a more positive perception of their health
status showing greater regression coefficient values. Smoking status and the number of chronic medical
conditions seem to have little or no direct correlation with the MMSE score.
Table 3 shows the results of subgroup analysis of depression development with MMSE. In terms
of age, a trend can be identified showing that groups of more advanced age have a smaller regression
coefficient regardless of gender and depression development groups. Regarding working status,
participation in social activities, and regular physical activities, those who responded positively
(working, yes, and yes, respectively) show a bigger regression coefficient than those who responded
negatively (non-working, no, and no) irrespective of gender and depression change groups. It is
noteworthy that in both genders and all depression change groups, those without chronic medical
conditions show a bigger regression coefficient than those who do suffer from such conditions.
Table 3. Results of subgroup analysis of depression development with MMSE.
Variables
Changes in Depressive State
Normal to
Normal
(Group A)
Normal to Depressive
(Group B)
Depressive to Normal
(Group C)
Depressive to Depressive
(Group D)
β β S.E p-Value β S.E p-Value β S.E p-Value
Men
Age
45–54 Ref. −0.6418 0.2217 <0.0001 0.08 0.1806 0.6576 −0.6064 0.2442 0.013
55–64 Ref. −0.5754 0.1482 0.0001 −0.1251 0.1306 0.3379 −1.1959 0.1528 <0.0001
65–74 Ref. −0.9235 0.1996 <0.0001 −0.5082 0.1655 0.0021 −1.5875 0.1814 <0.0001
≥75 Ref. −1.0562 0.2416 <0.0001 −0.8721 0.2569 0.0007 −2.2595 0.2417 <0.0001
Working status Working Ref. −0.6906 0.1172 <0.0001 −0.1564 0.0976 0.109 −1.0477 0.1103 <0.0001
Non–working Ref. −0.7559 0.1727 <0.0001 −0.6893 0.1796 0.0001 −1.8139 0.1787 <0.0001
Participation in
social activities
No Ref. −1.0705 0.3051 0.0005 −1.1854 0.2981 <.0001 −2.4268 0.2821 <0.0001
Yes Ref. −0.6741 0.1067 <0.0001 −0.214 0.0923 0.0204 −1.1992 0.105 <0.0001
Regular physical
activities
Yes Ref. −0.5601 0.1361 <0.0001 −0.3747 0.134 0.0052 −1.425 0.1509 <0.0001
No Ref. −0.8295 0.1499 <0.0001 −0.3982 0.1294 0.0021 −1.6323 0.1385 <0.0001
Number of chronic
medical conditions
None Ref. −0.5652 0.1382 <0.0001 −0.0218 0.1262 0.8631 −1.1953 0.1523 <0.0001
1 Ref. −0.8462 0.2021 <0.0001 0.0526 0.1637 0.748 −1.2027 0.1902 <0.0001
≥2 Ref. −0.8291 0.2142 <0.0001 −1.2408 0.199 0.0001 −2.166 0.2096 <0.0001
Women
Age
45–54 Ref. −0.1882 0.1775 <0.0001 −0.1052 0.1711 0.5388 −0.5266 0.1991 0.0082
55–64 Ref. −0.7177 0.1298 <0.0001 −0.2076 0.108 0.0547 −1.2455 0.1336 <0.0001
65–74 Ref. −0.6797 0.1783 0.0001 −0.3658 0.1523 0.0163 −1.6416 0.1714 <0.0001
≥75 Ref. −0.74 0.2771 0.0076 −0.9771 0.2568 0.0001 −1.7301 0.2672 <0.0001
Working status Working Ref. −0.3845 0.1479 0.0093 −0.3425 0.1318 0.0094 −1.0245 0.1524 <0.0001
Non–working Ref. −0.7139 0.1253 <0.0001 −0.5034 0.1124 <.0001 −1.5261 0.1302 <0.0001
Participation in
social activities
No Ref. −1.198 0.257 <0.0001 −1.1648 0.2368 <.0001 −2.1144 0.2333 <0.0001
Yes Ref. −0.5096 0.1038 <0.0001 −0.2597 0.0918 0.0047 −1.2726 0.1091 <0.0001
Regular physical
activities
Yes Ref. −0.4491 0.1389 0.0012 −0.3678 0.1263 0.0036 −1.502 0.1478 <0.0001
No Ref. −0.6907 0.1316 <0.0001 −0.5256 0.1181 <.0001 −1.425 0.1301 <0.0001
Number of chronic
medical conditions
None Ref. −0.3997 0.1466 0.0064 −0.2438 0.1379 0.077 −1.4042 0.1734 <0.0001
1 Ref. −0.6238 0.18 0.0005 −0.1692 0.1541 0.272 −1.1589 0.1664 <0.0001
≥2 Ref. −1.0232 0.1908 <0.0001 −0.9455 0.1702 <.0001 −1.9229 0.1859 <0.0001
4. Discussion
We investigated the association between the change in depressive state and cognitive function
multi-directionally by comparing every case of depressive state change (normal to normal, normal to
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depressive, depressive to normal, depressive to depressive). Our findings reveal that those who have
suffered from depression experience a decline in cognitive function. An interesting point is that people
experience cognitive impairment not only in the case of depression-onset (normal to depressive) but
also depression-remission (depressive to normal). Meanwhile, the latter case experiences moderate
decline in cognitive function when compared with the former case. We also examined some meaningful
results in terms of age, working status, participation in social activities, regular physical activities, and
number of chronic medical conditions.
Our results suggest that those who experience a change in depressive state undergo cognitive
impairment. In Table 2, the negative value of the regression coefficient for Group B indicates that the onset of
depression is associated with a decline in cognitive abilities, which is consistent with the findings of numerous
previous studies [4,5,20,21]. Meanwhile, the regression coefficient for Group C, also negative, indicates that
remission of depression is associated with a decline in cognitive abilities as well. Numerous studies report
the possibly persistent feature of cognitive impairment after remission of depression episodes [12,22–24].
Indeed, Maria Semkovska et al. state, “Deficits in selective attention, working memory, and long-term
memory persist in remission from a major depressive episode and worsen with repeated episodes” [10].
These findings are in line with preceding studies suggesting that antidepressant medication only remedies
patients’ mood disorders but cannot improve cognitive dysfunction [25,26]. It is inappropriate, however,
to propose that antidepressant medication is useless, because there is evidence of the efficacy of drugs:
“Antidepressant drugs mitigate cognitive dysfunction in some people with Major Depressive Disorder” [25].
Instead, we might be able to suggest that antidepressant medication cannot ‘fully’ improve cognitive
dysfunction. Then, it is notable that those whose depressive symptoms remit experience less decline in
cognitive abilities than those who develop depression. The negative value of the regression coefficient for
Group B in Table A5, which sets Group C as the reference value, agrees with this finding.
There are also meaningful results which can be derived from Tables 1 and 3. First, aging is
associated considerably with decline in cognitive function, which is in line with common sense and
preceding studies [27,28]. Not only do one’s cognitive abilities deteriorate as one gets older, but the
degree of decline in cognitive impairment increases as well. This can be verified from our results:
the older the population, the lower the mean MMSE score in Table 1 and the smaller the regression
coefficient in Table 3. Second, those living a stimulating life experience less cognitive impairment
accompanied with change in depressive state. Abovementioned ‘stimulating life’ corresponds to
‘working’, ‘participating in social activities’, and ‘doing regular physical activities’ in our study.
In Table 3, the absolute values of regression coefficients of those who work, participate in social
activities, and do regular physical activities are all smaller than the opposite. Numerous studies
concerning this issue are consistent with the results [29–34]. Third, those with a greater number of
chronic medical conditions experience more severe cognitive impairment accompanied with change in
depressive state. This can be inferred from the following tendency: the greater the number of chronic
medical conditions, the smaller the regression coefficient in Table 3. In this regard, Joshua Chodosh
et al. suggest that depressive symptoms and chronic disease contribute to poorer cognitive function
independently [35]. In other words, those with both depression and chronic disease experience more
intense cognitive decline than those without the latter. These findings also support previous research
suggesting that “performance on most cognitive measure was poorer in the presence of hypertension
or DM as compared with other chronic disease” [36].
Some limitations should be noted. First, the possible bias due to the nature of the survey method
should be addressed: the KLoSA database used for the study is based on self-reported investigation.
Because it is not a clinical diagnosis but a subjective judgement by the individual, it may not represent
the subject’s health condition as it is, whether intended or not. Second, the results may have been
exaggerated for the reason that the passage of time during the investigation may accompany cognitive
decline as mentioned above. Because our key variable—changes in depressive state—inevitably
involves the passage of time, regression coefficients of Tables 2 and 3 include not only the association
between changes in depressive state and cognitive function but also cognitive decline accompanying
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aging. Third, the causal link between changes in depressive state and cognitive function cannot be
addressed, because the study is not based on prospective study design. In this regard, it would be
enlightening to investigate the causal relationship between them with a prospective study design.
The strength of our study, however, is that we analyzed cognitive abilities corresponding to
depression change multi-directionally by comparing every case of depression change (normal to
normal, normal to depressive, depressive to normal, and depressive to depressive), whereas numerous
previous studies concentrated on cognitive impairment either when having developed depression
or having been cured of depression. With this wider viewpoint, direct comparison between changes
in cognitive abilities corresponding to two opposite depression change directions becomes possible,
making the study more comprehensive. Another characteristic of the study is that it examines the
degree of change in an individual’s own cognitive abilities, whereas most previous studies compared
subjects’ cognitive abilities with those of other individuals. In other words, while most previous
studies compared the cognitive abilities of a depressive with that of another who is in a normal mood,
our study compared the degree of change in cognitive abilities between four depression change groups.
Lastly, it is also noticeable that the MMSE, the measure of cognitive abilities, was employed as a raw
index, not as a criterion for dividing normal cognition, mild cognitive impairment, and dementia. As
the raw MMSE score is a continuous variable, it was possible to establish more meaningful intergroup
comparisons and concrete results.
5. Conclusions
In summary, there is a significant association between changes in depressive state and cognitive
function: regardless of the direction in which depressive state changes, cognitive function is damaged.
The degree of cognitive function being impaired is greater in the case of depression-onset than that of
depression-remission. It is also found that age, stimulating activities, and chronic conditions have a
remarkable relevance for cognitive decline accompanied with change in depressive state. The strength
of our research lies in the fact that interpretations were conducted by case-categorizing types of
depression change, which makes the discussion more comprehensive. However, due to the limitations
of the study design, causation cannot be addressed. Further studies using a prospective study design
would be worthwhile.
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Appendix A
Table A1. The effect size of three different models.
Variables
Crude Model Model 1 Model 2
β S.E. p-Value β S.E. p-Value β S.E. p-Value
Male
Normal to Normal Ref. Ref. Ref.
Normal to Depressive −1.408 0.112 <0.0001 −1.071 0.106 <0.0001 −0.717 0.102 <0.0001
Depressive to Normal −0.911 0.102 <0.0001 −0.563 0.097 <0.0001 −0.416 0.094 <0.0001
Depressive to Depressive −2.691 0.134 <0.0001 −2.087 0.120 <0.0001 −1.539 0.108 <0.0001
Female
Normal to Normal Ref. Ref. Ref.
Normal to Depressive −1.207 0.101 <0.0001 −0.934 0.098 <0.0001 −0.629 0.097 <0.0001
Depressive to Normal −0.871 0.092 <0.0001 −0.547 0.088 <0.0001 −0.430 0.087 <0.0001
Depressive to Depressive −2.476 0.114 <0.0001 −1.873 0.106 <0.0001 −1.413 0.104 <0.0001
Model 1 adjusted age, educational level, region, household income, working status. Model 2 adjusted age,
educational level, region, household income, working status, participants in social activities, perceived health status,
regular physical activities, smoking, alcohol intake, number of chronic medical conditions, weight change of ≥5kg
in the past year, number of cohabiting generations.
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Table A2. Post hoc analysis (Tukey method) of changes in depressive state for male individuals.
Comparisons Significant at the 0.05 Level are Indicated by ***.
Interesting Group
Comparison
Difference
Between Means Simultaneous 95% Confidence Limits
0–2 1.03292 0.72017 1.34568 ***
0–1 1.77209 1.45383 2.09036 ***
0–3 3.71874 3.46277 3.97471 ***
2–0 −1.03292 −1.34568 −0.72017 ***
2–1 0.73917 0.3447 1.13364 ***
2–3 2.68582 2.33964 3.03199 ***
1–0 −1.77209 −2.09036 −1.45383 ***
1–2 −0.73917 −1.13364 −0.3447 ***
1–3 1.94665 1.59548 2.29781 ***
3–0 −3.71874 −3.97471 −3.46277 ***
3–2 −2.68582 −3.03199 −2.33964 ***
3–1 −1.94665 −2.29781 −1.59548 ***
0: Normal to Normal, 1: Normal to Depressive, 2: Depressive to Normal, 4: Depressive to depressive.
Table A3. Post hoc analysis (Tukey method) of changes in depressive state for female individuals.
Comparisons Significant at the 0.05 Level are Indicated by ***.
Interesting Group
Comparison
Difference
Between Means Simultaneous 95% Confidence Limits
0–2 1.5348 1.20371 1.86589 ***
0–1 1.98415 1.6327 2.3356 ***
0–3 4.59168 4.3253 4.85806 ***
2–0 −1.5348 −1.86589 −1.20371 ***
2–1 0.44935 0.03806 0.86064 ***
2–3 3.05688 2.71541 3.39836 ***
1–0 −1.98415 −2.3356 −1.6327 ***
1–2 −0.44935 −0.86064 −0.03806 ***
1–3 2.60753 2.24629 2.96878 ***
3–0 −4.59168 −4.85806 −4.3253 ***
3–2 −3.05688 −3.39836 −2.71541 ***
3–1 −2.60753 −2.96878 −2.24629 ***
0: Normal to Normal, 1: Normal to Depressive, 2: Depressive to Normal, 4: Depressive to depressive.
Table A4. Results of analyzing factors associated with MMSE (Group B as a reference).
Variables
Men Women
β S.E p-Value β S.E p-Value
Changes in Depressive State
Normal to Normal 0.7169 0.1023 <0.0001 0.6289 0.0967 <0.0001
Normal to Depressive Ref. Ref.
Depressive to Normal 0.3009 0.1072 0.005 0.1988 0.0976 0.0417
Depressive to Depressive −0.8216 0.1249 <0.0001 −0.7841 0.1097 <0.0001
All covariates are adjusted for the analysis.
Table A5. Results of analyzing factors associated with MMSE (Group C as a reference).
Variables
Men Women
β S.E p-Value β S.E p-Value
Changes in Depressive State
Normal to Normal 0.4161 0.0944 <0.0001 0.4301 0.0865 <0.0001
Normal to Depressive −0.3009 0.1072 0.005 −0.1988 0.0976 0.0417
Depressive to Normal Ref. Ref.
Depressive to Depressive −1.1224 0.1175 <0.0001 −0.9829 0.1026 <0.0001
All covariates are adjusted for the analysis.
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Table A6. Results of analyzing factors associated with MMSE (Group D as a reference).
Variables
Men Women
β S.E p-Value β S.E p-Value
Changes in Depressive State
Normal to Normal 1.5385 0.1083 <0.0001 1.413 0.104 <0.0001
Normal to Depressive 0.8216 0.1249 <0.0001 0.7841 0.1097 <0.0001
Depressive to Normal 1.1224 0.1175 <0.0001 0.9829 0.1026 <0.0001
Depressive to Depressive Ref. Ref.
All covariates are adjusted for the analysis.
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